Showing results (51-60 of 70) with videos related to
Sort By:
Pageof 7
The Journal of Urology|December 22, 2020
Mutations in <i>HOGA1</i> do Not Confer a Dominant Phenotype Manifesting as Kidney Stone DiseaseRoi Bar, Efrat Ben-Shalom, Mordechai Duvdevani, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2023
Dialysis in Israeli Children between 1990 and 2020: Trends and International ComparisonsLilach C Regev-Epstein, Yaacov Frishberg, Miriam Davidovits, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 30, 2006
Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23Yaacov Frishberg, Nobuaki Ito, Choni Rinat, et al.Pediatric Nephrology (Berlin, Germany)|May 16, 2024
Diagnosis and management of primary hyperoxalurias: best practicesMini Michael, Elizabeth Harvey, Dawn S Milliner, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 22, 2025
Long-term Lumasiran Therapy Final Results from a Phase 2 Open-label Extension Study in Primary HyperoxaluriaYaacov Frishberg, Jaap W Groothoff, Sally-Anne Hulton, et al.American Journal of Human Genetics|August 28, 2010
Mutations in DHDPSL are responsible for primary hyperoxaluria type IIIRuth Belostotsky, Eric Seboun, Gregory H Idelson, et al.Pediatric Nephrology (Berlin, Germany)|August 1, 2022
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trialWesley Hayes, David J Sas, Daniella Magen, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 15, 2021
Phase 3 trial of lumasiran for primary hyperoxaluria type 1: A new RNAi therapeutic in infants and young childrenDavid J Sas, Daniella Magen, Wesley Hayes, et al.Clinical Journal of the American Society of Nephrology : CJASN|September 8, 2011
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasisCarla G Monico, Sandro Rossetti, Ruth Belostotsky, et al.Kidney International|January 30, 2009
Mutations of NPHP2 and NPHP3 in infantile nephronophthisisKálmán Tory, Caroline Rousset-Rouvière, Marie-Claire Gubler, et al.Pageof 7